266 related articles for article (PubMed ID: 27503655)
41. The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection.
Lutgring JD; Limbago BM
J Clin Microbiol; 2016 Mar; 54(3):529-34. PubMed ID: 26739152
[TBL] [Abstract][Full Text] [Related]
42. Performance of CarbaNP and CIM tests in OXA-48 carbapenemase-producing Enterobacteriaceae.
Yıldız SS; Kaşkatepe B; Avcıküçük H; Öztürk Ş
Acta Microbiol Immunol Hung; 2017 Mar; 64(1):9-16. PubMed ID: 28357923
[TBL] [Abstract][Full Text] [Related]
43. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Cercenado E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
[TBL] [Abstract][Full Text] [Related]
44. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
Demir Y; Zer Y; Karaoglan I
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
[TBL] [Abstract][Full Text] [Related]
45. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
Livermore DM; Oakton KJ; Carter MW; Warner M
Antimicrob Agents Chemother; 2001 Oct; 45(10):2831-7. PubMed ID: 11557477
[TBL] [Abstract][Full Text] [Related]
46. Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.
Woodworth KR; Walters MS; Weiner LM; Edwards J; Brown AC; Huang JY; Malik S; Slayton RB; Paul P; Capers C; Kainer MA; Wilde N; Shugart A; Mahon G; Kallen AJ; Patel J; McDonald LC; Srinivasan A; Craig M; Cardo DM
MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(13):396-401. PubMed ID: 29621209
[TBL] [Abstract][Full Text] [Related]
47. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
[TBL] [Abstract][Full Text] [Related]
48. Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae.
Woodford N; Eastaway AT; Ford M; Leanord A; Keane C; Quayle RM; Steer JA; Zhang J; Livermore DM
J Clin Microbiol; 2010 Aug; 48(8):2999-3002. PubMed ID: 20534805
[TBL] [Abstract][Full Text] [Related]
49. Comparison of imipenem and meropenem antibiotics for the MALDI-TOF MS detection of carbapenemase activity.
Rotova V; Papagiannitsis CC; Skalova A; Chudejova K; Hrabak J
J Microbiol Methods; 2017 Jun; 137():30-33. PubMed ID: 28390706
[TBL] [Abstract][Full Text] [Related]
50. Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae.
He Q; Chen W; Huang L; Lin Q; Zhang J; Liu R; Li B
Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):40. PubMed ID: 27328762
[TBL] [Abstract][Full Text] [Related]
51. Comparison of Carba NP-Direct, Carbapenem Inactivation Method, and β-CARBA Tests for Detection of Carbapenemase Production in Enterobacteriaceae.
Bayraktar B; Barış A; Malkoçoğlu G; Erdemir D; Kına N
Microb Drug Resist; 2019; 25(1):97-102. PubMed ID: 29694266
[TBL] [Abstract][Full Text] [Related]
52. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A;
J Antimicrob Chemother; 2018 Oct; 73(10):2738-2747. PubMed ID: 30053113
[TBL] [Abstract][Full Text] [Related]
53. Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms.
Yarbrough ML; Wallace MA; Potter RF; D'Souza AW; Dantas G; Burnham CD
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):187-195. PubMed ID: 31679102
[TBL] [Abstract][Full Text] [Related]
54. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the MBT STAR-Carba Assay for the Detection of Carbapenemase Production in
Cordovana M; Abdalla M; Ambretti S
Microb Drug Resist; 2020 Nov; 26(11):1298-1306. PubMed ID: 32412820
[TBL] [Abstract][Full Text] [Related]
56. Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae.
Gauthier L; Bonnin RA; Dortet L; Naas T
PLoS One; 2017; 12(2):e0170769. PubMed ID: 28158310
[TBL] [Abstract][Full Text] [Related]
57. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):183-6. PubMed ID: 26164275
[TBL] [Abstract][Full Text] [Related]
58. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
59. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the modified carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae.
Kuchibiro T; Komatsu M; Yamasaki K; Nakamura T; Nishio H; Nishi I; Kimura K; Niki M; Ono T; Sueyoshi N; Kita M; Kida K; Ohama M; Satoh K; Toda H; Mizutani T; Fukuda N; Sawa K; Nakai I; Kofuku T; Orita T; Watari H; Shimura S; Fukuda S; Nakamura A; Wada Y
J Infect Chemother; 2018 Apr; 24(4):262-266. PubMed ID: 29248418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
